Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. offers long-term value and growth potential

November 26, 2024
Amgen Inc. (NASDAQ: AMGN) continues to be a top value stock with promising long-term prospects. The company has recently gained the attention of Second Half Financial Partners LLC, as they have taken a position in Amgen Inc. This move demonstrates confidence in the company's ability to deliver solid returns for investors.

Commerce Bank is also wagering on Amgen's success, as they have acquired 5119 shares of the company. This bet on Amgen's future suggests that Commerce Bank sees great potential for growth and profitability.

Meanwhile, Strategy Asset Managers LLC has decided to reduce its holdings in Amgen Inc. It is important to note that this action does not necessarily reflect a negative outlook on the company. Portfolio adjustments are a common practice for asset managers and can be driven by a variety of factors.

Overall, Amgen Inc. remains an attractive investment option due to its strong financials and continuous advancements in the biotechnology space. The company's portfolio of innovative drugs and therapies, combined with its robust pipeline, positions it well for long-term success.

While it is always wise to consult with professionals, such as those at Stocks Prognosis, for investment advice, Amgen Inc. offers opportunities for investors looking for both value and growth in the healthcare sector.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


BIIBDecember 22, 2024Stifel downgrades Biogen on slow Alzheimer's drug launch uncertainty ahead  ~2 min.

Biogen Inc., a leading biotechnology company, is facing a setback as Stifel downgrades its stock due to uncertainty surrounding the launch of its Alzheimer's drug....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


BIIBDecember 19, 2024Biogen Inc.'s Stock Price Struggles as it Faces Mixed Financials  ~2 min.

Biogen Inc., a leading biotechnology company, is currently experiencing a struggle with its stock price as a result of its mixed financials....


BIIBDecember 21, 2024Biogen Inc.: A Closer Look at the Healthcare Sector Underperformance  ~2 min.

Biogen Inc., a leading biotechnology company, has been in the spotlight recently due to its underperformance in the healthcare sector....


BIIBDecember 29, 2024Biogen Inc. BIIB: Among the Cheap Healthcare Stocks to Buy Heading Into 2025  ~1 min.

Biogen Inc., a leading global biotechnology company, is considered one of the cheap healthcare stocks to buy heading into 2025....